Anvil Partners LLP invests in AccuRx SEIS/EIS round

AccuRx has completed an SEIS/EIS round raising a total of £355,000 from a number of business angels including Anvil Partners LLP. AccuRx is developing software to help doctors reduce inappropriate antibiotic prescribing, a leading cause of anti-microbial resistance. The funds are being used to build out the software platform and run a pilot study in a number of GP practices in Oxfordshire. AccuRx presented at an Angels in MedCity event in November 2016.